1+ hour, 38+ min ago   (362+ words) Rayner, a British ophthalmic medical product manufacturer, announced that the FDA has granted 510(k) clearance to its Sophi (Swiss Ophthalmology Innovation) phacoemulsification system. With its U.S. headquarters in Memphis, Tennessee, the global manufacturing company specializes in intraocular lenses (IOLs) and ophthalmic viscosurgical…...

6+ hour, 37+ min ago   (370+ words) A study recently published in Eye evaluated the demographic, ocular, and genetic risk factors for beta-zone peripapillary atrophy (beta-zone PPA) in Black individuals with primary open-angle glaucoma (POAG). In Bruch's membrane: PPA is called beta-zone PPA and has been described…...

1+ day, 3+ hour ago   (358+ words) Nanodropper is kicking off the new year with a new corporate identity as Mu Medical and expansion into a precision eyecare platform with two other companies: Bedo Solutions and Viseon Labs. The new entity is formally debuting this week during…...

1+ day, 3+ hour ago   (358+ words) Nanodropper is kicking off the new year with a new corporate identity as Mu Medical and expansion into a precision eyecare platform with two other companies: Bedo Solutions and Viseon Labs. The new entity is formally debuting this week during…...

1+ day, 11+ hour ago   (397+ words) Over a year after the U.S. Congress passed a bipartisan reform bill by Congress granting optometry physician-level recognition, optometrists (ODs) employed by the U.S. The Department of Veterans Affairs (VA) are officially on par with physician pay rates. The update follows an…...

2+ day, 6+ hour ago   (459+ words) A recent study published in Retina evaluated associations between glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and diabetic retinopathy (DR), diabetic macular edema (DME), and treatment-requiring DR/DME. The cardiovascular outcome trials (CVOTs) for GLP-1 RAs demonstrated significant cardiovascular disease…...

2+ day, 17+ hour ago   (503+ words) Ophthalmic biologics and device company Allotex, Inc. has secured conditional approval from the FDA for an investigational device exemption (IDE) to initiate a U.S.-based clinical study of its proprietary human collagen-based corneal implant. With a new leader appointed just last…...

6+ day, 6+ hour ago   (309+ words) Calling all retina specialists! Registration is officially available for the American Retina Forum (ARF) with Eyes On Eyecare (EOE) 2026, a virtual event and first-time collaboration kicking off in February. This professional community of retinal specialists centers on peer-to-peer learning, with…...

6+ day, 11+ hour ago   (174+ words) Allotex Inc., a commercial-stage ophthalmic company with active European market adoption, announced that the U.S. Food and Drug Administration (FDA) has conditionally approved its Investigational Device Exemption (IDE), authorizing the initiation of a U.S. clinical study for ALLO-1, its proprietary tissue-based solution…...

1+ week, 6+ hour ago   (636+ words) Findings from a recent article published in Ophthalmology evaluated the incidence of visual impairment (VI) and major structural complications in patients with punctate inner choroidopathy (PIC) as well as predictors of poor visual outcomes. PIC is a noninfectious inflammatory disorder characterized…...